Febuxostat is a xanthine oxidase inhibitor primarily used in the manufacturing of active pharmaceutical ingredients. It is a crystalline compound developed for pharmaceutical applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 144060-53-7
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
pharmaceutical intermediate
Pneumocandin C(0)
pharmaceutical raw material
Vebreltinib
pharmaceutical raw material
Ledipasvir acetone
pharmaceutical raw material
Ripretinib
pharmaceutical raw material
Febuxostat impurity 7
pharmaceutical intermediate
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid
BQSJTQLCZDPROO-UHFFFAOYSA-N
CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O